| NERV |
Minerva Neurosciences, Inc |
Common Stock, par value $0.0001 per share |
10% |
$17,970,807 |
|
4,330,315 |
|
Balyasny Asset Management L.P. |
31 Dec 2025 |
| XAIR |
Beyond Air, Inc. |
Common Stock, par value $0.0001 per share |
10% |
$2,581,092 |
|
12,290,913 |
0% |
Balyasny Asset Management L.P. |
31 Mar 2025 |
| LXEO |
Lexeo Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.9% |
$53,656,154 |
+$13,573,377 |
7,221,555 |
+34% |
Balyasny Asset Management L.P. |
31 Dec 2025 |
| XAIR |
Beyond Air, Inc. |
Common Stock, par value $0.0001 per share |
9.5% |
$1,671,553 |
|
763,266 |
0% |
Balyasny Asset Management L.P. |
31 Dec 2025 |
| CTNM |
Contineum Therapeutics, Inc. |
Class A Common Stock, par value $0.001 per share |
7.6% |
$26,435,304 |
|
2,312,800 |
|
Balyasny Asset Management L.P. |
31 Dec 2025 |
| IRD |
Opus Genetics Inc. |
Common Stock, par value $0.0001 per share |
7.4% |
$10,271,850 |
|
5,110,373 |
|
Balyasny Asset Management L.P. |
31 Dec 2025 |
|
Shapeways Holdings Inc |
Common Stock, par value $0.0001 per share |
7% |
|
|
500,000 |
|
Balyasny Asset Management L.P. |
31 Dec 2024 |
| VSTM |
Verastem Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$36,802,429 |
-$7,341,998 |
4,767,154 |
-17% |
Balyasny Asset Management L.P. |
31 Dec 2025 |
| SPR |
Spirit AeroSystems Holdings, Inc. |
Common Stock, par value $0.01 per share |
5.5% |
$251,115,504 |
+$105,610 |
6,505,583 |
+0.04% |
Balyasny Asset Management L.P. |
30 Sep 2025 |
| HPP |
Hudson Pacific Properties, Inc |
Common Stock, par value $0.01 per share |
5% |
$15,829,000 |
-$6,692,110 |
7,066,518 |
-30% |
Balyasny Asset Management L.P. |
31 Mar 2025 |
| CWH |
Camping World Holdings, Inc |
Common Stock, par value $0.01 per share |
4% |
$39,566,219 |
-$11,297,650 |
2,505,777 |
-22% |
Balyasny Asset Management L.P. |
30 Sep 2025 |
| LTRYW |
Lottery.com Inc |
Common Stock, par value $0.001 per share |
4% |
$1,642 |
|
164,247 |
|
Balyasny Asset Management L.P. |
03 Oct 2025 |
| AVTX |
Avalo Therapeutics Inc. |
Common Stock, par value $0.001 per share |
2.4% |
$7,446,338 |
-$6,409,202 |
439,312 |
-46% |
Balyasny Asset Management L.P. |
31 Dec 2025 |
| SHPWW |
Shapeways Holdings, Inc |
Common Stock, par value $0.0001 per share |
0.94% |
|
|
500,000 |
0% |
Balyasny Asset Management L.P. |
30 Jun 2025 |
| LPTX |
Leap Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Balyasny Asset Management L.P. |
31 Dec 2024 |
| ARCT |
Arcturus Therapeutics Holdings Inc. |
Common Stock, par value $0.001 per share |
0% |
$0 |
-$14,807,418 |
0 |
-100% |
Balyasny Asset Management L.P. |
31 Dec 2025 |